NYSE: CYBN - Cybin Inc.

半年間の収益性: -2.35%
配当利回り: 0.00%
セクタ: Healthcare

プロモーションスケジュール Cybin Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について Cybin Inc.

Cybin Inc., a clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog, which is in Phase 1/2a clinical trial to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine, which is in Phase 1 clinical trial for treating generalized anxiety disorders; and CYB005, a phenethylamine derivative, which in in preclinical stage to treat neuroinflammation.

さらに詳しく
It has also developed EMBARK, a psychological support model that integrates clinical approaches to promote supportive healing with psychedelic medicine. The company is headquartered in Toronto, Canada.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

IPO date 2019-09-13
ISIN CA23256X1006
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета cad
Сайт https://www.cybin.com
Цена ао 7.3
1日あたりの価格変動: +3.7% (7.3)
週ごとの価格変動: +3.84% (7.29)
月ごとの料金変更: -19.12% (9.36)
3ヶ月間の価格変動: -22.6% (9.78)
半年間の価格変動: -2.35% (7.752)
年間の価格変動: +1 610.73% (0.4425)
3年間の価格推移: +870.51% (0.78)
5年間の価格推移: +3 738.74% (0.1972)
10年間の価格推移: 0% (7.57)
年初からの価格変動: -20.65% (9.54)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0 0
P/BV 0.6298 10
P/E 0 0
EV/EBITDA 0.3199 10
合計: 5

効率

名前 意味 学年
ROA, % -40.45 0
ROE, % -42.43 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.0037 10
合計: 8.8

成長の衝動

名前 意味 学年
収益性 Revenue, % 0 0
収益性 Ebitda, % -818600 0
収益性 EPS, % 32682.95 10
合計: 6
さらに詳しく

機関 音量 共有, %
Point72 Asset Management, L.P. 30061112 4.04
Anson Funds Management LP 8924494 1.2
Alyeska Investment Group, L.P. 5683196 0.76
CVI Holdings, LLC 5225262 0.7
AdvisorShares Investments, LLC 1859181 0.25
PDS Planning, Inc 1153120 0.16
Propel Bio Management, LLC 850000 0.11
Simplify Asset Management, Inc. 500000 0.07
FNY Investment Advisers, LLC 402000 0.05
Lewis Asset Management, LLC 282000 0.04



スーパーバイザー 役職 支払い 生年
Mr. Eric So L.L.B. Co-Founder, President & Executive Chairman 458.88k 1976 (49 年)
Mr. Douglas L. Drysdale Chief Executive Officer 613.44k 1970 (55 年)
Mr. Paul Glavine Co-Founder, Chief Growth Officer & Director 458.88k 1989 (36 年)
Mr. Greg Cavers Chief Financial Officer 242.09k 1971 (54 年)
Mr. Aaron Bartlone Chief Operating Officer 379.12k 1967 (58 年)
Mr. John Kanakis Co-Founder 704.03k 1981 (44 年)
Dr. Alex L. Nivorozhkin Ph.D. Chief Scientific Officer N/A 1960 (65 年)
Ms. Lori Challenger Chief Compliance, Ethics & Administrative Officer N/A
Mr. Gabriel Fahel Chief Legal Officer & Corporate Secretary N/A 1976 (49 年)
Mr. George Tziras Chief Business Officer & Director 1981 (44 年)

住所: Canada, Toronto, 100 King Street West - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.cybin.com